We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

108 hedge funds and large institutions have $372M invested in Albireo Pharma Inc in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 45 increasing their positions, 27 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 27

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

29% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 17

23% more call options, than puts

Call options by funds: $2.2M | Put options by funds: $1.79M

6% more capital invested

Capital invested by funds: $353M → $372M (+$19.5M)

5% more funds holding

Funds holding: 103 → 108 (+5)

Holders
108
Holders Change
+5
Holders Change %
+4.85%
% of All Funds
1.86%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
22
Increased
45
Reduced
27
Closed
17
Calls
$2.2M
Puts
$1.79M
Net Calls
+$411K
Net Calls Change
-$1.21M

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$23M
2
Millennium Management
Millennium Management
New York
+$9.91M
3
TCM
Tang Capital Management
California
+$8.26M
4
SFM
Sphera Funds Management
Israel
+$7.42M
5
GKIM
GW&K Investment Management
Massachusetts
+$6.52M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$22.2M
2
NIP
Nicholas Investment Partners
California
-$8.56M
3
CC
Chicago Capital
Illinois
-$4.79M
4
JGC
J. Goldman & Co
New York
-$4.59M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$2.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$2.38M -$641K -30,985 -20%
BC
27
Birchview Capital
Vermont
$2.27M +$82.7K +4,000 +4%
SB
28
Samsara BioCapital
California
$1.94M – – –
N
29
Nuveen
North Carolina
$1.8M +$1.15M +55,774 +150%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$1.66M -$29K -1,402 -2%
Fiera Capital (Canada)
31
Fiera Capital (Canada)
Quebec, Canada
$1.64M +$1.55M +75,088 +141%
Point72 Asset Management
32
Point72 Asset Management
Connecticut
$1.51M +$1.62M +78,100 New
Jane Street
33
Jane Street
New York
$1.19M +$1.28M +61,652 New
Deutsche Bank
34
Deutsche Bank
Germany
$954K -$23.7K -1,144 -2%
HF
35
HRT Financial
New York
$939K +$1M +48,539 New
Charles Schwab
36
Charles Schwab
California
$907K +$10.7K +515 +1%
DekaBank Deutsche Girozentrale
37
DekaBank Deutsche Girozentrale
Germany
$823K +$207K +10,000 +29%
BGIM
38
Brandywine Global Investment Management
Pennsylvania
$816K -$33.8K -1,632 -4%
Swiss National Bank
39
Swiss National Bank
Switzerland
$792K – – –
Walleye Capital
40
Walleye Capital
New York
$739K +$790K +38,178 New
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$707K +$542K +26,231 +255%
ECM
42
ExodusPoint Capital Management
New York
$695K -$352K -17,031 -32%
WMSA
43
Weiss Multi-Strategy Advisers
New York
$678K +$724K +35,000 New
AC
44
Apogem Capital
New York
$668K -$9.66K -467 -1%
Goldman Sachs
45
Goldman Sachs
New York
$573K -$974K -47,114 -61%
Prudential Financial
46
Prudential Financial
New Jersey
$498K -$864K -41,800 -62%
M&T Bank
47
M&T Bank
New York
$484K +$75.1K +3,632 +17%
AllianceBernstein
48
AllianceBernstein
Tennessee
$443K – – –
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$425K -$2.21K -107 -0.5%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$412K +$29.4K +1,424 +7%
1
2
3 4 5

ALBO Hedge Fund Activity: Q3 2022 in Review

108 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q3 2022, worth a combined $372M — up 5.5% from $353M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ALBO positions and 17 closed out — a net gain of 5 holders — while 45 added to existing stakes and 27 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $23M. The largest seller was State Street, cutting an estimated $22.2M.

  • 108 institutional investors held Albireo Pharma Inc (ALBO) as of Q3 2022, up from 103 in Q2 2022.
  • Funds reported $372M of Albireo Pharma Inc stock for Q3 2022, up 5.5% quarter-over-quarter.
  • 22 funds opened new Albireo Pharma Inc positions in Q3 2022 and 17 closed out, a net change of +5 holders.
  • The largest Albireo Pharma Inc buyer in Q3 2022 was Deep Track Capital, an estimated $23M added.
  • The largest Albireo Pharma Inc seller in Q3 2022 was State Street, an estimated $22.2M sold.

Based on aggregated 13F filings for Q3 2022.